Johnson & Johnson (NYSE:JNJ) Earnings Preview: Strong Performance Expected

Johnson & Johnson is set to release its quarterly earnings with an estimated EPS of $2.78 and projected revenue of $23.7 billion.The company's stock has increased by 31% this year, outperforming the S&P 500's 14% rise.JNJ has a history of outperforming earnings estimates, with an average earnings surprise of 5.96% over the last two quarters.Johnson & Johnson (NYSE:JNJ) is a leading global healthcare company known for its wide range of products, including pharmaceuticals, medical devices, and consumer health ...